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Gain at Xq28 Mediated by an Unusual Recombination
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Irene Madrigal,5 Montserrat Mila,5 Elly Pijkels,3 Isabel Fernandez,6 Ju¨rgen Kohlhase,7 Christiane Spaich,8
Anita Rauch,4 Jean-Pierre Fryns,3 Peter Marynen,1,2 and Guy Froyen1,2,*
We report on the identiﬁcation of a 0.3Mb inherited recurrent but variable copy-number gain at Xq28 in affectedmales of four unrelated
families with X-linked mental retardation (MR). All aberrations segregate with the disease in the families, and the carrier mothers show
nonrandom X chromosome inactivation. Tiling Xq28-region-speciﬁc oligo array revealed that all aberrations start at the beginning of
the low copy repeat LCR-K1, at position 153.20Mb, and end just distal to LCR-L2, at 153.54Mb. The copy-number gain always includes
18 annotated genes, of which RPL10, ATP6AP1 and GDI1 are highly expressed in brain. From these, GDI1 is the most likely candidate
gene. Its copy number correlates with the severity of clinical features, because it is duplicated in one family with nonsyndromicmoderate
MR, is triplicated in males from two families with mild MR and additional features, and is present in ﬁve copies in a fourth family with
a severe syndromic form of MR. Moreover, expression analysis revealed copy-number-dependent increased mRNA levels in affected
patients compared to control individuals. Interestingly, analysis of the breakpoint regions suggests a recombination mechanism that
involves two adjacent but different sets of low copy repeats. Taken together, our data strongly suggest that an increased expression of
GDI1 results in impaired cognition in a dosage-dependent manner. Moreover, these data also imply that a copy-number gain of an indi-
vidual gene present in the larger genomic aberration that leads to the severeMECP2 duplication syndrome can of itself result in a clinical
phenotype as well.Introduction
The general use of microarray-based comparative genome
hybridization (array-CGH) has tremendously changed our
view of the genome and especially its variability. Moreover,
it is now well accepted that submicroscopic genomic
imbalances are a major cause of developmental disorders
due to copy-number changes of dosage-sensitive genes.
On theX chromosome, a high incidence of causalmicrodu-
plications was found, demonstrating that increased
expression of tightly regulated genes can disturb normal
cognitive development as well.1 The best known example
is Pelizaeus-Merzbacher disease (PMD [MIM 312080]),
caused by mutation in or deletions or duplications of the
gene encoding proteolipid protein-1 (PLP1, [MIM 300401])
at Xq22. We previously described two novel nonrecurrent
duplications on the X chromosome including HUWE1
(MIM300697) orMECP2 (MIM300005).2,3 As also observed
for the PLP1 copy-number change, these aberrations have
different breakpoints, precluding nonallelic homologous
recombination (NAHR) because such an event results
in recurrent aberrations of the same size and location.
Therefore, replication-based recombination mechanisms
at genomic regions with a presumed complex architectureThe Americanwere proposed as an explanation of the copy-number gains
at the PLP1 andMECP2 loci.4–6 Copy-number gains almost
always result in duplications although complex rearrange-
ments resulting in triplications have been detected for the
MECP2 and PLP1 loci as well.7,8 In these cases, the severity
of the clinical features of these patients seems to correlate
with the increased copy number.
Recurrent rearrangements are generally mediated by
NAHR between ﬂanking segmental duplications or low
copy repeats (LCRs; genomic duplications of > 1 kb
and > 90% identity), which result in deletions, duplica-
tions, ampliﬁcations, or inversions of the intermediate
genomic segments.9 Several recurrent aberrations due to
NAHR between two highly homologous repeat units have
been described on the X chromosome, such as those at
Xp22.3, which result in X-linked ichthyosis (MIM
308100),10 and those at Xq28, leading to incontinentia pig-
menti (MIM 300248).11 Xq28 is of speciﬁc interest because
it contains many sets of LCRs in close proximity to each
other, which render this region prone to recombination
that might lead to disease.4,7 In the nonrecurrent MECP2
duplication syndrome (MIM 300260), increased dosages
ofMeCP2aremost likely sufﬁcient for the severephenotype
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including known mental retardation (MR)-related genes
such as SLC6A8 (MIM 300036), L1CAM (MIM 308840),
FLNA (MIM 300017), and GDI1 (MIM 300104).4 Therefore,
a potential additive effect of increased dosages of one of the
other duplicated genes is expected to be very small. Hence,
these genes are thought not to be dosage sensitive.
Here, we present four unrelated MR families with
an apparent complex copy-number gain of an identical
0.3 Mb region at Xq28, which harbors the MR-associated
genes FLNA and GDI1 but not MECP2. Notably, the copy
number of GDI1 perfectly correlates with the severity of
the disease, which ranges from moderate nonsyndromic
MR in a patient with a duplication of GDI1 to severe MR
with epilepsy and brain anomalies in two brothers with
ﬁve copies of GDI1.
For the recurrent aberration reported here, the break-
points seem to be located within LCRs from two different
classes, pointing to a peculiar NAHR mechanism that can
occur at several other locations in the genome as well.
Subjects and Methods
Patients
The screening protocols were approved by the appropriate
institutional review board of the university hospitals of Leuven
(Belgium), Barcelona (Spain), Erlangen (Germany), and Freiburg
(Germany), and informed consent was obtained from the parents
of the affected patients. Genomic DNA from patients and from
healthy controls was isolated from peripheral blood in accordance
with standard procedures and was stored at 4C.
Array-CGH and Quantitative PCR Analysis
Full-coverage X chromosome bacterial artiﬁcial chromosome
(BAC) array-CGHwas performed on DNA of the probands of fami-
lies 1 and 2, essentially as described elsewhere.1,12 Cy5:Cy3 ratios
for each clone were plotted in log2 scale relative to the position on
the X chromosome. Clones with log2 ratios outside the0.3 to 0.3
interval were considered aberrant. Full-coverage X chromosome
BAC array-CGH on family 3 was performed as described previ-
ously.13 Finally, full-genome oligo-array-CGH on family 4 was
performed with the use of premade 244K oligo arrays (Agilent
Technologies, Palo Alto, CA, USA) spanning the entire genome,
resulting in an average spacing of 12 kb. The hybridization was
performed essentially as described elsewhere.14 Hybridization
and feature extraction was performed as described elsewhere,15
and data were visualized by means of the CGHAnalytics 3.4
software (Agilent Technologies).
Conﬁrmation, copy-number analysis, and initial delineation of
the extent of the duplication were done by real-time quantitative
polymerase chain reaction (qPCR) with the use of SYBRgreen on
a LC480 apparatus (Roche, Basel, Switzerland). qPCR primers
were designed with the LightCycler Probe Design2 software
(Roche) and are given in Table S1, available online. Data were
normalized against the PORCN (MIM 300651) locus at Xp11.23.
All samples were run in duplicate, and data were analyzed with
the instrument software and further analyzed in Excel via the
comparative ddCt method (Sequence Detection System, bulletin
no. 2; Applied Biosystems, Foster City, CA, USA). Screening for
additional patients with a similar duplication in this region was810 The American Journal of Human Genetics 85, 809–822, Decembperformed by qPCR with the use of the primer pairs within the
FLNA and GDI1 genes. Quantitation of the LCR sets (K1/K2 and
L1/L2) was performed with LCR-speciﬁc primer pairs that recog-
nize both members of each set.
Fine Mapping of the Copy-Number Gains at Xq28
Duplication mapping and exact copy-number analysis were per-
formed in all four families. Differentially labeled patient versus
male control DNA samples were hybridized onto a custom-
designed 4 3 44K oligo array (Agilent Technologies) that covers
the repeat-masked 152.70Mb to 153.65Mb region at tiling resolu-
tion. In addition, differentially labeled DNA from carrier mothers
of families 2 and 4 were hybridized versus a female control sample
to these custom arrays. Statistical data analysis was performed on
the Cy3 and Cy5 intensities (g/rMeanSignal and g/rBGUsed), as
provided by the Feature Extraction software, version 10.1. The
log2 ratios were normalized with Loess normalization on the basis
of the log ratios measured for the subset of clones within region
between 152,765 kb and 152,865 kb on the X chromosome.
Clones that were ﬂagged by the Feature Extraction software as
absent were omitted from subsequent analysis. Replicate clones
were averaged, and unmapped clones were omitted from the anal-
ysis. Next, a heterogeneous Hidden Markov Model, BioHMM, was
ﬁtted on the log2 ratios and the corresponding clone information.
Finally, the merging algorithm16 was applied for merging of
segment levels if the distributions of the log ratios of the segments
were not signiﬁcantly different and if the difference of the two pre-
dicted level values were too close. Analysis was performed at the
VIB Microarray Facility (Leuven, Belgium) in the R programming
environment, in conjunction with the packages (a.o., snapCGH,
and aCGH) developed within the Bioconductor project. All posi-
tions are based on the UCSC genome browser (NCBI build 36.1,
Hg18, March 2006).
cDNA Expression Analysis by qPCR
Total RNA was extracted from white blood cells or Epstein Barr
Virus–transformed peripheral-blood lymphocytes (EBV-PBLs) as
described elsewhere.3 Real-time quantitation was performed with
the SYBRgreen method on 50 ng of cDNA with cDNA-speciﬁc
primers (Table S1) as described previously.3 The housekeeping
genes GUSB (MIM 611499) and HPRT (MIM 308000) were used
for normalization. Each 15 ml reaction well contained 0.5 mM of
each primer and 13 SYBRgreen qPCR Master Mix (Roche). Reac-
tion setup and data analysis were carried out as described above.
X Chromosome Inactivation
Lymphocyte-derived genomic DNA was subjected to the
androgen-receptor gene (MIM 313700) methylation assay for
assessment of the methylation status.17 A ROX-labeled genotyp-
ing marker, 100-500 (Applied Biosystems), was added, and the
samples were separated on an ABI3130xl automated DNA
sequencer (Applied Biosystems) and analyzed with the GeneMap-
per analysis software (Applied Biosystems) for peak-position and
area-intensity calculations. Data were further processed in Excel.
Results
Clinical Description of the Families
Family 1 is of Belgian origin and consists of four affected
males in two generations (Figure 1A). The index patienter 11, 2009
(IV.2) is a 6-year-old boy that came to our attention because
of delayed psychomotor development, tiptoeing, and mild
atactic gait. He was born after a normal pregnancy, occur-
ring at term within normal parameters. He started to
walk at the age of 21 months and had delayed speech
development. Also, his ﬁne motor skills are delayed. At
clinical examination, he presented with mild facial asym-
metry (Figure S1A). Growth parameters are within the
normal range (length 113 cm [75th percentile], occipito-
frontal circumference [OFC] 51 cm [50th percentile]). He
has a nasal speech and mild articulation problems. There
is a syndactyly of toes II and III bilaterally. His gait is mildly
atactic, but there are no other cerebellar signs. Tendon
reﬂexes in the lower legs are brisk, with clonus of both
Achilles tendons and a positive Babinski sign. He has
normal social interaction, and no behavioral problems
have been reported. Cognitive evaluation via the Wechsler
Preschool and Primary Scale of Intelligence showed
a moderate mental retardation, with a total IQ of 50. MRI
of the brain showed a mildly enlarged fourth ventricle.
Karyotype and FMR1 mutation analysis was normal.
Family history revealed the presence of several additional
individuals with a similar phenotype. His maternal uncle,
individual III.10, was born at term after a normal preg-
nancy. His psychomotor development was reported to be
retarded, necessitating special schooling. Now, at the age
of 37 yrs, he is moderate mentally retarded and lives and
works on the farm of his healthy brother. On clinical exam-
ination, his OFC is 59 cm (> 97th percentile), with a high
forehead, and his length is 170 cm (10th percentile). He
has deep-set eyes, external strabismus of the right eye,
and a prominent chin (Figure S1B). His speech is mildly
dysarthric, and he also shows brisk tendon reﬂexes in the
lower limbs and an inability to walk on his heels. He has
a shy and quiet behavior. The two other affected males in
the family, individuals III.16 and III.19, are brothers. The
birth of the oldest brother, individual III.16, was traumatic.
He developed a severe psychomotor delay, pronounced
Figure 1. Pedigrees of Families with an
Increased Copy Number at Xq28
(A) Family 1, (B) family 2, (C) family 3, and
(D) family 4. The result of the qPCR with
the GDI1 primer set is indicated below
the individual as ‘‘N’’ in case of a normal
copy number, and with ‘‘þ’’ in case of an
increased copy number.
hemiplegia, deafness, and epilepsy.
His younger brother, individual III.19,
is moderately retarded and works in a
sheltered work environment. At clin-
ical examination, his length is 171 cm
(10th percentile) and his OFC is 56 cm
(75th percentile). He has a high
forehead, deep-set eyes, alternating
external strabismus (Figure S1C), and
unclear speech. His thumbs are short, and there is cuta-
neous syndactyly of toes II and III bilaterally. His gait is
stiff, but there are no signs of ataxia or spasticity in the
lower limbs. He has a shy and friendly behavior. All carrier
females in this family are asymptomatic.
Family 2 is of German origin and consists of two affected
brothers (Figure 1B). The oldest brother (II.1) was born
after a normal pregnancy and within normal birth param-
eters (length 53 cm, weight 3680 g, OFC 34 cm). At the age
of 8 months, the parents remarked that he showed almost
no interest in his environment and was still very ﬂoppy.
An MRI of the brain was performed and showed a classical
Dandy-Walker malformation, with cerebellar hypoplasia
and agenesis of corpus callosum. He developed seizures
at 15 months of age and responded well to antiepileptic
treatment. Recent examination at the age of 3.5 years
showed a severely delayed boy who does not sit or walk
and says only two meaningful words. He had surgery for
hip dysplasia and is susceptible to colds and infections.
His height and weight are normal (length 100 cm [25th–
50th percentile], weight 14 kg [10th percentile]), but he is
microcephalic (OFC is 46 cm; < 3rd percentile). His ears
are large, and he has upslanting palpebral ﬁssures, epi-
canthic folds, and thin lips. Because of axial hypotonia,
he has skull and thorax asymmetry. He has short toes
and peripheral muscular hypertony. He also has
nystagmus. The clinical history in his younger brother
(II.2) is similar: He was born after a normal pregnancy
and within normal parameters. He also has a Dandy-
Walker malformation, with agenesis of the cerebellar ver-
mis and hypoplasia of the corpus callosum, but has no
epilepsy to date. He was diagnosed with mild unilateral
renal reﬂux. At his last examination, at the age of 19
months, he crawled but could not sit alone and showed
axial hypotonia and hypertonic extremities. His OFC is
41 cm (< 3rd percentile), and his weight is 8.5 kg (< 3rd
percentile). He has facial features similar to those of his
older brother. Both brothers have a normal karyotype.The American Journal of Human Genetics 85, 809–822, December 11, 2009 811
Mutations in FMR1 (MIM 309550), L1CAM (MIM 308840),
and ARX (MIM 300382), as well as subtelomeric rearrange-
ments, were excluded. Duplication of theMECP2 gene was
excluded by MLPA. The mother has a normal phenotype.
Family 3 is of Spanish origin and was brieﬂy reported as
case 6 by Madrigal et al.13 The index patient (II.2) belongs
to a family with three affected males (Figure 1C). He was
born to nonconsanguineous parents at 8 months of a preg-
nancy complicated by an acute pancreatitis. Because of
neonatal seizures and cyanotic crises, he stayed in neonatal
intensive care for 10 days. Imaging of the brain showed
ventricular dilatation and large asymmetric cisternamagna.
His gross motor milestones were within the normal range.
His speech development was delayed. At age 7, a clinical
examination showed mild dysmorphism with micro-
cephaly (OFC 49.5 cm [< 3rd percentile]), a high palate,
medial eyebrow ﬂare, and prominent ears. He showed
psychomotor difﬁculties in the handling of objects, hyper-
kinetic behavior, and learning disabilities. He attended
school with extra educational support and was diagnosed
with mild MR, with an IQ of 58. Neurological examination
was normal. At present, he is unemployed and lives at
home. He speaks in short sentences. His younger sister
also carries the triplication but has a normal phenotype. X
chromosome inactivation analysis in the phenotypically
normal carriermother showed a 100% skewed inactivation.
We have no clinical details on twomaternal uncles (I.3 and
I.4) who are institutionalized.
Patient 4 is a sporadic case of German origin, born to
healthy, unrelated parents (Figure 1D). The family history
is negative regarding MR and congenital anomalies. He
was born at 38 wks of gestation after a normal pregnancy,
within normal birth parameters (birth weight 3040 g,
length 51 cm, OFC 33 cm). He was investigated because of
mild global psychomotor delay, with sitting at 12 months
and walking at 20 months. Now, at the age of 2 yrs, he has
begun to speak some words. There is mild dysmorphism,
with brachcephaly, broad forehead, hypotelorism, and
epicanthus inversus that is more pronounced at the left
side. He has a rather ﬂat midface with a ﬂat nasal root and
a short philtrum. He has a high palate and a small chin.
OFC is 48 cm (25th percentile) and length is 83 cm (10th
percentile). Metabolic screening, electroencephalography,
and hearing test results were all normal. Results of an ultra-
sound examination of the brain during the newborn period
and a CT scan at 8 months were normal. Karyotype was
normal, as was FMR1 analysis.
Array-CGH and qPCR Analysis
Cohybridization of DNA from proband IV.2 of family 1
(labeled with Cy5) and DNA from an unrelated male MR
patient (labeled with Cy3) on our BAC X-array revealed
a microduplication at Xq28 (Figure S2A) with three clones
having log2-normalized Cy5/Cy3 intensity ratios that
deviate signiﬁcantly from the arbitrarily set ‘‘normal’’
interval of 0.3 to 0.3. These are clone CTD-2511C7 (ratio
of 0.98) and the completely overlapping clones RP5-812 The American Journal of Human Genetics 85, 809–822, Decemb865E18 and RP5-1087L19 (ratios of 0.50 and 0.52, respec-
tively). Clone RP11-103M23 had a ratio of 0.27, which is
just within the normal interval, indicating that only part
of it could be affected. The ﬂanking clones with normal
ratios were RP11-119A22 (ratio of 0.06) at the proximal
side and RP11-115M6 (ratio of 0.05) at the distal side,
indicating that the aberration has a maximal size of
0.5 Mb. Similarly, we found aberrant ratios for the same
clones in the proband II.1 of family 2 by the same X-array
(Figure S2B). However, the deviation from the normal
interval was much bigger compared to that obtained for
family 1. Ratios for clones CTD-2511C7, RP5-865E18,
RP5-1087L19, and RP11-103M23 were 1.71, 1.27, 1.10,
and 0.49, respectively, indicating that this region would
be present more than two times in the genome. qPCR
conﬁrmed both aberrations in the probands with primer
sets 10 to 13 (Table S1). Compared to controls, a copy-
number difference of 2.78 (50.43) was found for family 1,
indicating a triplication, whereas for family 2, relative
abundances of 4.80 (51.17) were detected, strongly point-
ing to ﬁve copies of that region (Figure S3). Segregation
analysis using the same qPCR primer set showed that
both aberrations segregate with the disease because
increased copy-number values were also found for the
affected males III.10 and III.19 for family 1 and II.2 for
family 2, whereas the unaffected males III.9 and III.17 for
family 1 yielded values close to 1.0. As expected, the obli-
gate carrier mothers (III.11 in family 1 and I.2 in family 2),
but also the grandmother of the proband in family 1 (II.5),
carry the aberration (data not shown).
In family 3, the aberrationwas detected as three deviating
clones spanning about 0.3 Mb, with the use of a different
X-array platform described elsewhere.13 The Cy5/Cy3 log2
ratio of these clones was 0.88 (50.10), indicating an
increase greater than two-fold although the ratios obtained
from different platforms cannot be compared. However,
when compared to controls, qPCR revealed a copy number
of 3.21 (50.28) (Figure S3). The aberration in family 4
was detected with a whole-genome oligo array. Elevated
log2 ratios (0.93 5 0.34) were obtained for 49 oligos
(average spacing of 5.3 kb) within the region 153.21 Mb
to 153.53 Mb. qPCR analysis conﬁrmed the duplication
because a relative copy number of 1.82 (50.19) (Figure S3)
was obtained in the proband of this family compared to
control male samples. The mother also carries the aberra-
tion, as demonstrated by the qPCR value of 1.48 (data not
shown). The location and extent of the aberrations are
schematically illustrated in Figure 2A. Interestingly, a
duplication of 190 kb within this aberrant region was
detected with the latter oligo array in a female patient as
well as her healthy father, demonstrating the polymorphic
nature of this aberration. This normal copy-number variant
covers the region 153,355,101 to 153,542,123 (striped bar
in Figure 2A) with increased log2 ratios for 27 oligos (data
not shown).
The copy-number gain we identiﬁed in the four families
was not found in 138 X chromosomes from controls, norer 11, 2009
Figure 2. Schematic Representation of the Xq28 Region, 152.90–153.60 Mb, Showing the Recurrent Aberration Detected in Four
Unrelated Families
(A) Indicated from top to bottom; the location of the qPCR primer pairs (1–17); annotated genes present in the interval; and the LCRs
within the region. The ampliﬁed region is indicated at the bottom with the horizontal dark bar, which is ﬂanked by the light bars with
a normal copy number. The horizontal striped bar represents a copy-number polymorphism identiﬁed in a healthy male.
(B) Magniﬁcation of the start and end positions of the four aberrations. The vertical arrows point to the positions of these sites, demon-
strating that they are located at the beginning of LCR K1 and at the end of LCR L2, respectively. The locations of the different regions
(R2 to R4, Ki and Li), as referred to in the text, are shown as well.was it reported in the polymorphic database of genomic
variants (DGV).
Precise Mapping of the Aberrations
For mapping and copy-number analysis of the aberra-
tions, we performed custom oligo-array-CGH analysis on
affected individuals of the four families and two carrier
mothers (arrays and data are available at GEO with acces-
sion numbers GPL9083 and GSE17813, respectively). Vari-
ability for the LCRs JA, JB, and JC (region R1 in Figures 3
and 4) harboring the opsin gene cluster (MIM 303800) is
evident from these arrays but is not further discussed
here. For family 1, we independently hybridized patients
III.19 and IV.2 and found identical data demonstrating
the robustness of this assay. The aberration started at
153.218 Mb and ﬁnished at 153.535 Mb, yielding an
aberration size of 317 kb. However, the copy number was
not equal throughout this aberration. The region R2
(153.218 to 153.277 Mb), which includes the LCR set
K1/K2 as well as the FLNA (MIM 300017) and EMD (MIM
300384) genes is present in two copies (mean ratio of
0.58) (Table S2) as schematically illustrated in Figure 3A.
The same copy number (mean ratio of 0.63) was found
for the region R4 (153.440 to 153.535 Mb) that includes
the second LCR set L1/L2 with the CTAG1A/B (MIM
300156) and CTAG2 (MIM 300396) genes. Region R3 in
between both LCR sets (153.277 to 153.440 Mb) was
present in three copies (mean ratio of 0.97) (Table S2)The Americanand carries the genes RPL10 (MIM 312173), DNASE1L1
(MIM 300081), TAZ (MIM 300394), ATP6AP1 (MIM
300197), GDI1 (MIM 300104), FAM50A (MIM 300453),
PLXNA3 (MIM 300022), LAGE3, UBL4A (MIM 312070),
SLC10A3, FAM3A (MIM 300492), G6PD (MIM 305900),
and IKBKG (MIM 300248) (Figure 3A). Family 2 (patient
II.1) had a very similar proﬁle except that the copy number
for each subregion was different, i.e., three copies for R2
and R4 (mean ratio of 0.99 for 153.218 to 153.276, and
1.07 for 153.428 to 153.542 Mb) and ﬁve copies for R3
(mean ratio of 1.43) (Figure 3B). The same proﬁle was
obtained for his mother (I.2), although the ratios were
smaller because of the presence of the normal X chromo-
some. In family 3 (patient II.2), the borders of the aberrant
subregions as well as the mean ratios were almost the same
as those obtained for family 1, revealing two copies for R2
(153.218 to 153.273 Mb; mean 0.76) and R4 (153.443 to
153.530Mb;mean 0.82) (Figure 4A and Table S2) and three
copies for the R3 region in between. Finally, in family 4
(patient II.1), the aberration was somewhat different in
that R2 was present in two copies (mean 0.53), followed
by three copies of only a 31 kb interval (R3’: 153.277
to 153.308 Mb: mean 0.91) harboring the genes RPL10,
DNASE1L1, and TAZ. The ﬂanking telomeric region was
duplicated again up to LCRL2 (R4’: 153.308 to 153.535Mb)
(Figure 4B). The copy numbers of the different regions
(R2 to R4) were conﬁrmed by qPCR from at least two inde-
pendent experiments (data not shown).Journal of Human Genetics 85, 809–822, December 11, 2009 813
The aberrant region thus contains 18 annotated genes
(Table 1). On the basis of the oligo-array data, FLNA and
EMD are duplicated in families 1, 3, and 4 and thus present
in two copies, whereas three copies are present in family 2.
The genes RPL10, DNASE1L1, and TAZ are present in three
copies in families 1, 3, and 4, whereas family 2 carries ﬁve
copies. Finally, ATP6AP1,GDI1, FAM50A, PLXNA3, LAGE3,
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Figure 3. Custom 44K Oligo-Array-CGH
Plots for Analysis of the Copy Numbers
within theRegion 152.70Mb to153.65Mb
at Xq28
(A) Patient IV.2 of family 1.
(B) Patient II.1 of family 2.
The borders of the copy-number-variable
regions (R1 to R4) are indicated by vertical
lines with the positions of the breakpoints
shown. The mean log2 Cy5/Cy3 ratio
(y axis) of each region is given at the right.
Below each plot the Ensembl view of the
corresponding region is shown with the
LCR sets (J, K, L) indicated. At the bottom,
we show a schematic representation of the
copy number of each region, based on the
array-CGH data.
UBL4A, SLC10A3, FAM3A, G6PD, and
IKBKG are present in two copies in
family 4, three in families 1 and 3,
and ﬁve in family 2.
Of the genes within the aberrations,
GDI1 shows highest expression in
brain, and the expression levels of
RPL10 and ATP6AP1 are relatively
high according to Unigene and Gene-
cards. Moderate brain mRNA levels
were found for FLNA, UBL4A, and
FAM3A, whereas all other genes had
low to undetectable expression in
brain tissue (Table 1). In situhybridiza-
tion in mouse brain showed strongest
signals in the hippocampus for GDI1,
RPL10, and ATP6AP1 (Allen mouse
brain atlas). Taking into account the
polymorphic variant identiﬁed in
the normal male sample the genes
within the aberrations that remain as
prime candidate genes for a dosage-
sensitive effect on brain develop-
ment are FLNA, RPL10, ATP6AP1, and
GDI1.
Bioinformatic Analysis
of the Breakpoint Regions
On the basis of our high-resolution
oligo-array mapping, all aberrations
start at exactly the same posi-
tion between oligomers located at
153,217,820 (normal ratio) and
153,218,037 bp (aberrant ratio), which coincides with the
start of LCR K1 (Figure 2B). The end positions in the
probands of families 1, 3, and 4 are located in between
oligos at 153,535,824 (aberrant) and 153,535,842 bp
(normal). For family 2, the end is located 7 kb more distal
at 153,542,213 bp (last aberrant oligo), showing that all
four distal breakpoints map just distal to LCR L2 and the814 The American Journal of Human Genetics 85, 809–822, December 11, 2009
CTAG2 gene (Figure 2B). Therefore, the size of this recurrent
aberration is 317 kb in families 1, 3, and 4 and 324 kb in
family 2. Most likely, the breakpoints are located within
segmental duplications of two different LCR sets, with the
proximal set K1/K2 and the distal set L1/L2. LCR K1
(153.218 to 153.229 Mb; direct orientation) is 11.3 kb in
size and shows > 99.6% identity with its counterpart LCR
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Figure 4. Custom 44K Oligo-Array-CGH
Plots for Analysis of the Copy Numbers
within theRegion 152.70Mb to153.65Mb
at Xq28
(A) Patient II.2 of family 3.
(B) Patient II.1 of family 4.
The borders of the copy-number-variable
regions (R1 to R4) are indicated by vertical
lines with the positions of the breakpoints
shown. The mean log2 Cy5/Cy3 ratio
(y axis) of each region is given at the right.
Below each plot the Ensembl view of the
corresponding region is shown with the
LCR sets (J, K, L) indicated. At the bottom,
we show a schematic representation of the
copy number of each region, based on the
array-CGH data.
K2 (153.266 to 153.277 Mb; indirect
orientation), located 37 kb more telo-
meric (Figure 2). The 37 kb region in
between this set of K-LCRs, which we
will call Ki, harbors the FLNA and
EMD genes. The distal breakpoint is
located at the end of the 35.7 kb large
LCR L2 (153.494 to 153.530 Mb; indi-
rect orientation). L2 has > 99% iden-
tity with L1 (153.437 to 153.472 Mb;
direct orientation), which is located
22 kb more centromeric. The ‘‘in
between’’ region, called Li, does not
harbor any genes. All four copy-
number gains thus seem to be ﬂanked
by unrelated oppositely oriented
LCRs (Figure 2). To investigate the
possibility that the recombination
occurred at the identiﬁed break-
point regions, we aligned a 2 kb
sequence surrounding the common
proximal breakpoint region (centered
at 153,217,930 bp) with a 2 kb region
at the distal breakpoint region of
families 1, 3, and 4 (centered at
153,535,833 bp) by using PipMaker.
Homology was found for only one
AluYf4 fragment in the proximal 2 kb
sequence with three Alu repeats of
different subclasses (AluSg, AluSp,
and AluJo) in the distal sequence, but
these repeats did not span the break-
point regions. Next, the possibility of
NAHR between the different LCR sets was investigated by
the use of Pipmaker to align the sequences of K1/K2 with
L1/L2. This alignment only revealed homology of short
interspersed repeat elements (SINEs) of the Alu subfamily
present at 8% in K1/K2 and 36% in L1/L2. These SINEs are
scattered throughout the LCRs and could have induced
a NAHR event.The American Journal of Human Genetics 85, 809–822, December 11, 2009 815
Table 1. Annotated Genes within the Recurrent Duplication at Xq28
Start Position End Position Gene ID Strand MIM Numbera Expression Brain Levelsb
153230091 153252845 FLNA - 300017, 300049 Ubiquitous 101
153260981 153263075 EMD þ 310300 Ubiquitous 19
153279912 153283874 RPL10 þ Ubiquitous 608
153281816 153281950 SNORA70 þ nd nd
153282773 153293621 DNASE1L1 - Many 11
153293071 153303259 TAZ þ 300069,302060 Ubiquitous 23
153310172 153318056 ATP6AP1 þ Ubiquitous 565
153318715 153325008 GDI1 þ 300104 Ubiquitous 1642
153325702 153332190 FAM50A þ Many 33
153339817 153355179 PLXNA3 þ Many 20
153358435 153360790 LAGE3 - Several 14
153365250 153368126 UBL4A - Ubiquitous 82
153368842 153372189 SLC10A3 - Many 8
153387700 153397567 FAM3A - Many 79
153412800 153428981 G6PD - 305900 Ubiquitous 57
153423653 153446455 IKBKG þ 308300 Ubiquitous 32
153466610 153468269 CTAG1A þ nd nd
153499059 153500714 CTAG1B - nd nd
153533445 153535036 CTAG2 - Few 0
nd denotes no data.
a MIM numbers are provided for associated clinical conditions.
b Numbers based on Unigene (relative to 1,104,300 transcripts).Toward a Recombination Model
In order to postulate a recombination model for this recur-
rent rearrangement for which a variable copy number was
obtained, we ﬁrst hypothesized a simple (direct or indirect)
tandem ampliﬁcation event, which is found in most
nonrecurrent duplication and ampliﬁcation events. We
designed primer pairs at both sides of the deduced
breakpoint regions and performed long-range PCR with
different primer combinations at either side of the
presumed breakpoint regions as described elsewhere.4 We
did not obtain unique PCR bands for the patients in
comparison to controls, making this type of simple rear-
rangement unlikely. Next, we hypothesized an inversion
at Xq28 with breakpoints in between or within the two
sets of LCRs (Ki and Li) in a patient’s ancestor. If so, the
inversion would invert the orientation of a subunit of
each LCR set, making the region prone to NAHR, which
could result in a variable copy-number gain (schematically
illustrated in Figure S4). To test this inversion hypothesis,
we designed forward and reverse primers at several loca-
tions within the unique sequences of Ki and Li. Because
we obtained PCR products of the correct sizes for all 5 to
6 kb subregions that span the entire normal (noninverted)
sequence of both Ki and Li regions in our patients as well as
in controls, we did not get any evidence for such an inver-816 The American Journal of Human Genetics 85, 809–822, Decembsion. Moreover, long-range PCR on DNA from patients
with several primer combinations, of which one primer
was located in Ki and the other in Li, did not result in
PCR products not found in controls (data not shown).
Finally, this model implies that the copy number should
be four in family 2, which does not ﬁt our qPCR data.
Therefore, we did not ﬁnd any evidence for the inver-
sion-driven rearrangement model. All our data thus
indicate that NAHR between LCRs of the same class
provides the most likely mechanism. However, this makes
cloning of the junction breakpoints an impossible task
because of the > 99% identity between the LCR subunits
(K1 and K2, and L1 and L2) and the multiple possible
NAHR-driven inversion events that could have taken place
between the subunits of each set.
On the basis of the oligo-array data, the copy number of
both R2 and R4 regions is two in families 1, 3, and 4,
demonstrating that these regions are duplicated. The inter-
vening region (R3 for families 1 and 3; R3’ for family 4),
however, has a copy number of three. In family 2, the
copy numbers of R2 and R4 are three, whereas that of
the intervening region R3 is ﬁve. These data are in agree-
ment with NAHR, as schematically illustrated in Figure 5.
Therefore, we propose a NAHR-driven model in which
the triplication in families 1, 3, and 4 occurred betweener 11, 2009
L1 and L2 on two different chromatids during meiosis I,
yielding an isodicentric X chromatid intermediate, directly
followed by a second NAHR event between K1 and K2 with
a chromatid of the other homologous chromosome
(Figure 5). This two-step mechanism results in two copies
of R2 and R4 (and partially R4’), and three copies of the
intervening R3 sequences (and R3’). For family 2, an addi-
tional NAHR event resulted in three copies of R2 and R4
and ﬁve copies of R3. This model is in agreement with
our data, taking into account a partial loss of one copy in
family 4 as the result of an aberrant NAHR event (see
Discussion).
mRNA Expression Studies
For expression analysis, we focused on those genes that
have the highest levels of expression in brain (GDI1,
RPL10, and ATP6AP1) or for which mutations have been
reported to play a role in XLMR (GDI1 and FLNA). First,
we measured the stability of expression of these four genes
in EBV-PBLs derived from ﬁve control individuals (three
males and two females), normalized to GUSB expression.
A highly stable expression pattern was obtained for three
genes (GDI1: 1.00 5 0.18; ATP6AP1: 1.00 5 0.20; FLNA:
1.00 5 0.17), demonstrating a tight regulation of mRNA
levels of these genes. Expression of RPL10 was somewhat
more variable (1.00 5 0.66) in this cell type, although
unrelated to sex. Moreover, the expression levels of the
four genes within the aberration in EBV-PBLs was fairly
Figure 5. Recombination Model that
Can Explain the Variable Copy-Number
Gains at Xq28
(A) The model is based on two consecutive
NAHR events in meiosis I. The ﬁrst is
between L1 and L2 on different chroma-
tids directly followed by NAHR between
K1 and K2, present on homologous chro-
matids.
(B) In family 2, the copy number was
extended to ﬁve because of a third NAHR,
most likely between sister chromatids in
meiosis II.
high because mean dCt values (Ct
gene – Ct GUSB) were always below
or equal to zero (GDI1: 0.5; RPL10:
1.0; ATP6AP1: 0.0; FLNA: 0.5).
Finally, relative expression of murine
Gdi1, normalized to Hprt, was mea-
sured in cortex and hippocampus of
ﬁve male mice. Highly stable mRNA
levels were obtained for both tissue
types (data not shown). Next, qPCR
analysis on cDNA from patient III.19
of family 1 revealed a 3- to 4-fold
increase in mRNA levels of GDI1,
RPL10, and ATP6AP1, whereas the
mRNA level of FLNA was only 2-fold
higher when compared to controls (Figure 6). In family 2
with ﬁve copies, lymphocytes obtained from both affected
brothers (II.1 and II.2) had GDI1, RPL10, ATP6AP1, and
FLNA mRNA levels 8-, 12-, 6-, and 5-fold higher than
controls, respectively. The expression of three control
genes located at other locations on the X chromosome,
HPRT (Xq26.2),HUWE1 (Xp11.22), and PORCN (Xp11.23),
did not show signiﬁcantly altered cDNA levels from the
patients from both families when compared to controls
(Figure 6). In family 3, only the GDI1 expression levels
were measured in total RNA extracted from blood lympho-
cytes, normalized to GUSB. qPCR revealed a 4-fold increase
in two affected males (I.3 and II.2) in comparison with two
male controls (data not shown). Gene expression levels
could not be tested in patient 4 because of unavailability
of material.
X-Inactivation
Analysis of the X-inactivation pattern in carrier females of
the families revealed a preferential use of the normal
X chromosome not carrying the copy-number gain. In
family 1, the proband (IV.2) carries the 327 allele at the
AR locus. His carrier mother (III.11) has the alleles 321/
327 with 85% of the cells inactivating the X chromosome
with the 327 allele. The grandmother via maternal line
(II.5), who is also a carrier, inactivates the same chromo-
some in 83% of her cells. X-inactivation analysis in
the carrier mothers of family 2 (this study) and family 3The American Journal of Human Genetics 85, 809–822, December 11, 2009 817
Figure 6. mRNA Expression Analysis of
GDI1, RPL10, ATP6AP1, and FLNA in
Affected Members of Families 1 and 2
with a Copy-Number Gain at Xq28
cDNA was prepared from RNA extracted
from blood (controls, family 2) or EBV-PBL
cell lines (controls, family 1). Compared to
controls, all affected individuals showed
signiﬁcant increased mRNA levels for all
four genes. Expression was determined by
qPCR and normalized to the expression
of HPRT. Expression levels are calculated
relative to the mean levels obtained in
the control samples (fold difference; y
axis). Standard deviations of at least two
independent experiments are indicated
for each bar.showed a skewed inactivation of 94% (own data) and
100%,13 respectively. In family 4, the carrier mother (I.2)
has the AR alleles 316/321 and inactivates the 316 allele
that is transmitted to her affected son, in 70% of her cells.
Discussion
In males, duplication of any part of the X chromosome
except the pseudoautosomal region leads to functional dis-
omy of the genes located within the aberration. We have
shown that increased gene dosage of XLMR genes can
result in an MR phenotype, showing that a two-fold
increase of the apparently critical quantity of the corre-
sponding protein can affect normal cognitive develop-
ment.1–3,13,18 This phenomenon most likely holds for
many other brain-expressed genes that are not implicated
in any disease to date and reﬂects the central neuronal
homeostasis that is critical for normal brain function.19
Therefore, the use of array-CGH in the study of mental
retardation remains essential.
We identiﬁed three XLMR families and one sporadic
patient carrying a copy-number gain of apparently the
same 0.3 Mb region at Xq28. The aberrant region that
was not present in DGV contains 18 annotated genes of
which GDI1 and FLNA have previously been associated
with X-linked mental retardation. Rab GDP-Dissociation
Inhibitor 1 (GDI1) is a central regulator of Rab GTPase
family members. GDI1 recycles Rab proteins from the
membrane and sequesters the inactive GDP-bound form
of Rab in the cytosol for use in multiple rounds of trans-
port. The balance between the membrane-bound form of
Rab and the cytosolic reserve pool of the Rab-GDI1
complex is critical for vesicular trafﬁcking and neurotrans-
mittor release.20 To guarantee this delicate balance, a crit-
ical dosage of GDI1 protein is required. Inactivating muta-
tions in GDI1 are associated with nonsyndromic X-linked
mental retardation (MIM 300104).21 However, it can be
envisaged that increased dosage might also affect the
complex Rab GTPase molecular switches, involved in
neuronal cell signaling. No animal model for increased818 The American Journal of Human Genetics 85, 809–822, DecemGdi1 expression has been reported to date. Indeed, we
demonstrated highly stable GDI1 mRNA levels at least in
EBV-PBLs and blood lymphocytes from controls. The other
duplicated gene implicated in a neurodevelopmental
phenotype, FLNA, is associated with a broad range of
congenital disorders affecting multiple organs.22 It codes
for Filamin A, a widely expressed protein that crosslinks
the actin in a regulated fashion into either networks or
stress ﬁbers that give the cell the ability to respond to
environmental cues. Loss-of-functionmutations, although
lethal in males, result in defective neuronal migration
leading to periventricular nodular heterotopia (PVNH
[MIM 300049]) in females. On the contrary, clustered
missense mutations in FLNA are associated with a diverse
spectrum of congenital malformations in males and
females, referred to as otopalatodigital spectrum disorders
(OPD [MIM 300017]).22 We did not observe any anomalies
affecting the skeletal system or neuronal migration deﬁcits
in our group of patients. Interestingly, Clayton-Smith and
coworkers recently suggested that increased FLNA gene
dosage may lead to intestinal pseudo-obstruction and
bladder dysfunction, as observed in seven families.23
However, we did not detect these features in any of our
families with duplication including FLNA. Moreover, a
polymorphic copy-number gain including FLNA has been
reported in a male24 and is present in the Database of
Genomic Variants (DGV) as variation_31575.
Two other genes with high expression in brain are
located within the aberration (RPL10 and ATP6AP1). Of
these, the RPL10 gene that codes for a ribosomal protein
has been associated with autism and MR.25 Because both
genes also showed signiﬁcantly increased mRNA levels at
least in lymphocytes from two patients compared to
controls, we cannot exclude an effect of increased dosages
of both genes. The triplication of RPL10 in family 4 with
just moderate MR argues against this gene as the cause of
the dosage-dependent phenotype because it is also present
in three copies in families 1 and 3 with a more severe
phenotype. The correlation of gene dosage with pheno-
typic severity, however, is valid for ATP6AP1 and GDI1.
Identiﬁcation of additional aberrations in this region orber 11, 2009
functional in vitro or in vivo studies will help to pinpoint
the causal gene. Moreover, the role of other genes within
the aberration, such as UBL4A and FAM3A, cannot be
excluded even though the apparent 190 kb copy-number
polymorphism identiﬁed in a normal male individual
seems to exclude a contribution of a double dosage of
both genes in family 4. Nevertheless, their involvement
in more than two-fold-increased dosages remains specula-
tive. Of the remaining genes, four have already been impli-
cated in unrelated diseases not associated with cognitive
alterations (Table 1).
The clinical phenotype in families 1, 3, and 4 that carry
a duplication or triplication is nonsyndromic mild to
moderate MR, with some mild nonconsistent dysmorphic
features in families 1 and 3 with the triplication. Of special
note are the ventricular aberrations seen in both families,
a large fourth ventricle in family 1, and a ventricular dila-
tation in family 3. In contrast, the two brothers of family
2 with ﬁve copies of this region display amuchmore severe
phenotype, with severe developmental delay, hypotonia,
epilepsy, and progressive microcephaly, together with
a Dandy-Walker malformation. The difference in pheno-
typic severity of both patients of family 2 compared to
the patients of the other families described here can be
attributed to the much higher mRNA levels of brain-
expressed genes. A correlation between gene dosage and
severity has also been demonstrated for PLP1 in Peli-
zaeus-Merzbacher disease,8 ampliﬁcation of chromosomal
4q21 region including SNCA [MIM 163890] in parkin-
sonism,26 and triplication of MECP2.7
Another conclusion from this study is that an increased
copy number of individual genes present in a contiguous
genomic aberration can in itself result in a clinical pheno-
type too. Indeed, in some patients with a duplication of
theMECP2 region, the affected genomic interval described
here is contained within the duplication.4,6 However,
the phenotype associated with the MECP2 duplication
syndrome is apparently not related to the number of
genes involved because of the essential and causal role of
increased MECP2 dosages. Our ﬁndings now illustrate
that an increased dosage of genes within theMECP2 dupli-
cation can, in itself, also result in an MR phenotype, albeit
much milder, and thus could have a modest effect on the
phenotype of patients with the MECP2 duplication
syndrome. The most likely candidate gene is GDI1 because
it is highly expressed in brain especially in the hippo-
campus, mutations herein lead to XLMR, and it is stably
expressed inmouse brain including hippocampus, suggest-
ing a tightly regulated expression of this gene. A three- or
even ﬁve-fold-increased dosage is thus very likely to
worsen the phenotype. However, additional functional
evidence is required to prove this hypothesis. The clinical
features of our patients described in this study do not
resemble at all the speciﬁc ones observed in patients with
the MECP2 duplication syndrome, which argues against
a position effect onMECP2mRNA levels. Expression levels
in EBV-PBLs derived from the proband of family 1 wereThe Americanwell within the variability found in control samples (data
not shown).
The carrier mothers show a nonrandom X-inactivation,
which seems to be correlated with the copy number of
GDI1 in that the carrier mothers of families 2 and 3 with
four and two additional copies, respectively, (almost)
completely skewwhereas this pattern is 85% in themother
of family 1, with two additional copies, and 70% in the
mother of family 4, who has one more copy of the gene.
Finally, the precise location and size of the aberrant
region in all four families appears to be highly similar
although the exact breakpoint sites could not be deter-
mined, probably because of the involvement of LCRs at
the proximal as well as the distal breakpoint regions. In all
four families, the aberrations start exactly at the beginning
of LCR K1 and stop at the end of LCR L2 (just distal to
CTAG2 in families 1, 3, and 4 and 7 kb more distal to that
site in family 2). Even though the breakpoint positions are
unknown, the four identiﬁed rearrangements point to
a common mechanism that involves a member of the
K- and L-type of LCRs. The lack of any homology between
both sets of LCRs precludes NAHR between members of
both LCR sets. The mechanism of Fork Stalling and
Template Switching (FoSTeS),5 microhomology-mediated
break-induced replication (MM-BIR),4,27 or coupled homo-
logous and nonhomologous recombination28 is not very
likely for this type of rearrangement given that these
mechanisms have been described for nonrecurrent aberra-
tions, which use microhomology at their junctions. Here,
we propose a model in which the triplication in families
1, 3, and 4 resulted from two successive NAHR events
between complementary LCRs during meiosis I with an
isodicentric X chromatid as an intermediate (Figure 5).
Interestingly, a similar model for a complex rearrangement
at 8p23 has been proposed earlier. This group reported on
two cases with a duplication and triplication on 8p23.1
and 8p23.2, respectively, and a third case with a dicentric
chromosome 8, and they hypothesized a recombination
model that consists of NAHR between two unrelated
LCR sets (OR-REP and MYOM2-REP) during meiosis in
heterozygous carriers of a polymorphic 8p23.1 inversion.29
The triplication of a smaller fragment (R3’) in family 4 can
then be explained by an erroneous NAHR event in which
the K-LCR set together with a smaller repeat such as a
LINE or SINE is used for recombination. Indeed, the break-
point region as deﬁned by the oligo array (153,308,
905–153,308,932 bp; Table S2) is directly ﬂanked by several
LINEs and SINEs (UCSC browser). Such erroneous NAHR
events have been described for other rearrangements.29
Moreover, our data provide evidence that a third NAHR
event between sister chromatids in meiosis II can generate
a further expansion of the copy number, as has been
detected for family 2. We were unable to clone the junc-
tions, which is not surprising given the very high sequence
homology between the LCR subunits and the multiple
rearrangements that take place between both classes
of LCRs.30,31 We did not ﬁnd any evidence for theJournal of Human Genetics 85, 809–822, December 11, 2009 819
alternative ‘‘polymorphic inversion’’-based model. Inver-
sion polymorphisms have been found in other diseases
as a requirement for recurrent aberrant genomic
rearrangements. Recurrent deletions and duplications on
17q21.3132–34 and recurrentdeletions associatedwith Sotos
syndrome35 are prime examples. Also, a potential inversion
at this Xq28 site has not been reported yet and actually is
not very likely because it could lead to disruption of the
FLNA or EMD genes that would result in disease. Finally,
a reciprocal deletion of the aberrant region described here
has not been reported, strongly indicating that deletion of
at least one of these genes is not compatible with life.
Indeed, absence of, e.g., the IKBKG gene is lethal inmales.11
Our data corroborate other studies that point to genomic
instability of loci that contain multiple segmental duplica-
tions. In particular, the Xq28 region is known to be instable
because of the many repeats resulting in several microrear-
rangements leading to disease.4,7 Our data, however, indi-
cate that the way these rearrangements are established
can be the result of several different mechanisms. Because
many similar LCR-rich regions exist in the human genome,
it is expected that similar variable copy-number aberrations
exist. Detecting the aberration therefore is not sufﬁcient.
Deﬁning the precise copy number of it can be very informa-
tive in explaining apparently similar aberrations with
highly variable phenotypes. Finding other recurrent aberra-
tions, which are ﬂanked by two different LCR sets, will
establish the proposed model as a new mechanism that
can drive evolution but can also result in disease.
Supplemental Data
Supplemental Data include two tables and four ﬁgures and can be
found with this article online at http://www.cell.com/AJHG.
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